Relapse rates and enhancing lesions in a phase II trial of natalizumab in multiple sclerosis

Paul O'Connor, David Miller, Katherine Riester, Minhua Yang, Michael Panzara, Catherine Dalton, Katherine Miszkiel, Omar Khan, George Rice, William Sheremata, G. J. Barker, D. G. MacManus, C. Webb, C. Middleditch, S. Lewis, T. Pepple, E. Riddle, C. Coombs, M. Agius, D. RichmanJ. Adams, M. Buonocore, J. Al-Omaishi, K. Markopoulou, K. Healey, P. Sorensen, D. Bates, J. Forsyth, J. Curlis, P. English, L. Blumhardt, V. Orpe, T. Jaspen, J. Bowen, M. Chang, H. Lew, M. Burke, T. Richards, J. L. Carter, D. Dodick, J. Takata, M. Malikowski, K. Nelson, D. A.H. Cross, J. Trotter, D. Derrington, J. Lauber, C. Martinez, G. Foster, T. Conturo, V. Devonshire, J. Oger, L. Wang, W. Morrison, L. Costley, C. Hawkins, C. Mathews, C. Gibson, J. Hebert, I. Rozentsvit, L. Capolino, J. P. Kelly, M. Kaufman, S. Putman, A. Diedrich, R. Follmer, S. Dombrowski, C. Graves, B. Harwick, A. C. Tselis, M. Din, C. Caon, M. Cochran, Z. Latif, R. P. Lisak, M. Zvartau-Hinds, L. Metz, J. Scott, D. Patry, M. Yeung, J. Heuser, C. Wallace, S. Curtis, A. Miller, E. Drexler, M. J. Keilson, K. Bruining, A. Schneider, R. Wolintz, L. Sciarra, H. Oltazewska, R. S. Murray, A. Bowling, R. E. Kramer, K. Bracht, C. O'Brien, L. Seeberger, J. Leitch, E. Prenger

Research output: Contribution to journal › Article › peer-review

38 Scopus citations

Fingerprint

Dive into the research topics of 'Relapse rates and enhancing lesions in a phase II trial of natalizumab in multiple sclerosis'. Together they form a unique fingerprint.

Medicine & Life Sciences